1. Home
  2. NTRA vs TWLO Comparison

NTRA vs TWLO Comparison

Compare NTRA & TWLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$197.88

Market Cap

29.2B

Sector

Health Care

ML Signal

HOLD

Logo Twilio Inc.

TWLO

Twilio Inc.

HOLD

Current Price

$196.03

Market Cap

30.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
TWLO
Founded
2003
2008
Country
United States
United States
Employees
N/A
5587
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
29.2B
30.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
TWLO
Price
$197.88
$196.03
Analyst Decision
Strong Buy
Buy
Analyst Count
15
24
Target Price
$259.07
$151.54
AVG Volume (30 Days)
1.4M
2.6M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
0.65
N/A
EPS
N/A
N/A
Revenue
$210,939,000.00
N/A
Revenue This Year
$18.08
$14.44
Revenue Next Year
$19.65
$8.21
P/E Ratio
N/A
$526.76
Revenue Growth
N/A
N/A
52 Week Low
$131.81
$91.84
52 Week High
$256.36
$203.71

Technical Indicators

Market Signals
Indicator
NTRA
TWLO
Relative Strength Index (RSI) 46.96 72.98
Support Level $187.27 $117.98
Resistance Level $204.34 N/A
Average True Range (ATR) 10.36 7.71
MACD -1.12 2.01
Stochastic Oscillator 28.02 89.31

Price Performance

Historical Comparison
NTRA
TWLO

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About TWLO Twilio Inc.

Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.

Share on Social Networks: